Plexus Corp.'s stock plummeted 11.73% in the pre-market session on Thursday, following the company's disappointing outlook for fiscal year 2025 that missed analyst expectations.
While Plexus reported better-than-expected earnings for the first quarter of fiscal 2025, with adjusted EPS of $1.73 beating the consensus estimate of $1.59, the company's guidance for the second quarter and full year fell short of Wall Street projections.
For the second quarter, Plexus forecasted adjusted earnings of $1.46 to $1.61 per share and revenue of $960 million to $1 billion, lower than analysts' expectations of $1.60 adjusted EPS and $1.02 billion revenue. The company also reported weakness in the Healthcare/Life Sciences and Aerospace/Defense sectors, which impacted its first-quarter revenue.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。